RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $29,013 | -23.5% | 27,500 | 0.0% | 0.03% | -23.8% |
Q2 2023 | $37,950 | +21.6% | 27,500 | +5.8% | 0.04% | +82.6% |
Q1 2023 | $31,200 | -3.2% | 26,000 | 0.0% | 0.02% | -4.2% |
Q4 2022 | $32,240 | +79.1% | 26,000 | +4.0% | 0.02% | +84.6% |
Q3 2022 | $18,000 | -43.8% | 25,000 | 0.0% | 0.01% | -43.5% |
Q2 2022 | $32,000 | -57.3% | 25,000 | +6.4% | 0.02% | -52.1% |
Q1 2022 | $75,000 | +31.6% | 23,500 | 0.0% | 0.05% | +33.3% |
Q4 2021 | $57,000 | -31.3% | 23,500 | 0.0% | 0.04% | -37.9% |
Q3 2021 | $83,000 | -20.2% | 23,500 | 0.0% | 0.06% | -18.3% |
Q2 2021 | $104,000 | +30.0% | 23,500 | 0.0% | 0.07% | +20.3% |
Q1 2021 | $80,000 | +2.6% | 23,500 | +9.3% | 0.06% | -9.2% |
Q4 2020 | $78,000 | +62.5% | 21,500 | +7.5% | 0.06% | +38.3% |
Q3 2020 | $48,000 | +71.4% | 20,000 | +29.0% | 0.05% | +62.1% |
Q2 2020 | $28,000 | +40.0% | 15,500 | +17.0% | 0.03% | +20.8% |
Q1 2020 | $20,000 | -23.1% | 13,250 | +8.2% | 0.02% | 0.0% |
Q4 2019 | $26,000 | – | 12,250 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |